'Watershed moment’ as London medtech closes £1.75m funding round

Jun 4, 2018 · bdaily.co.uk


The medtech company behind a new blood filtration device has secured seven-figure funding.

London-based MediSieve Ltd secured the £1.75m boost from a mix of new and existing investors.

Private capital network 24Haymarket led the round by contributing £632k, with director Marek Gumienny joining the MediSieve board as non-executive director.

MediSieve said the investment will "contribute greatly" to further research and development while providing a strong source of future capital.

The company currently operates from office and lab space at Imperial College London’s Translation & Innovation Hub (I-HUB).

MediSieve is best known for its magnetic blood filtration technology, which targets blood-borne diseases by magnetically filtering specific disease-causing components in the bloodstream.

Read Complete Article

RT @techspace: A new episode of #RVoSu is up! We sit down w/ @Seedrs Co-Founder Jeff Lynn (@JeffSeedrs) to hear about the early days, Europ…

2 years 16 million+ journeys 3,900 jobs supported Two years on, the Night Tube has been an even bigger success th… https://t.co/r9zGTzfI0j

#TechX365: only 4% of the UK has access to full-fibre broadband, compared to South Korea's 93% https://t.co/SviTadr2Fj

Google: To be clear, this is how we track you even with Location History turned off https://t.co/V8LvWqsfGo

Is the UK out of step by promoting the merits of ecigarettes? https://t.co/Pik1KvS9WQ